Abstract
An efficient synthesis of (R)-2-benzylmorpholine has been accomplished starting from L-phenylalaninol by employing stereospecific rearrangement of β-amino alcohol using catalytic amount of (CF3CO)2O as a key step.
Keywords: Morpholine, appetite suppressant agent, stereospecific rearrangement, debenzylation, alcohol, amine.
Graphical Abstract
[1]
(a) Cossy, J.; Pardo, D.G.; Dumas, C.; Mirguet, O. De champs, I.; Metro, T-X.; Burger, B.; Roudeau, R.; Appenzeller, J.; Cochi A. Chirality, 2009, 21, 850.
(b) Teresa, B.M.; Adilia, J.C.M.; Maycockd, C.D.; Michaud, T. Tetrahedron, 2005, 61, 7960.
(b) Teresa, B.M.; Adilia, J.C.M.; Maycockd, C.D.; Michaud, T. Tetrahedron, 2005, 61, 7960.
[2]
(a) Chavez, S.A.; Martinko, A.J.; Lau, C.; Pham, M.N. Cheng, K.; Bevan, D.E.; Mollnes, T.M.; Yin, H. J. Med. Chem., 2011, 54, 4659.
(b) Kiss, L.; Fulo, F. Chem. Rev., 2014, 114, 1116.
(c) Kopach, M.E.; Singh, U.K.; Koberski, M.E.; Trankle, W.G.; Murray, M.M.; Pietz, M.A.; Forst, M.B.; Stephenson, G.A.; Mancuso, V.; Giard, T.; Vanmarsinille, M.; Defrance, T. Org. Process Res. Dev., 2009, 13, 209.
(b) Kiss, L.; Fulo, F. Chem. Rev., 2014, 114, 1116.
(c) Kopach, M.E.; Singh, U.K.; Koberski, M.E.; Trankle, W.G.; Murray, M.M.; Pietz, M.A.; Forst, M.B.; Stephenson, G.A.; Mancuso, V.; Giard, T.; Vanmarsinille, M.; Defrance, T. Org. Process Res. Dev., 2009, 13, 209.
[3]
(a) Pu, L.; Yu, H.B. Chem. Rev., 2001, 101, 757.
(b) Alexandre, F.T.; Pedro, M.P.G.; Carlos, A.M.A. Chem. Rev., 2009, 109, 418.
(c) Subba Reddy, U.V.; Chennapuram, M.; Seki, C.; Kwon, E.; Okuyama, Y.; Nakano, H. Eur. J. Org. Chem., 2016, 24, 4124.
(b) Alexandre, F.T.; Pedro, M.P.G.; Carlos, A.M.A. Chem. Rev., 2009, 109, 418.
(c) Subba Reddy, U.V.; Chennapuram, M.; Seki, C.; Kwon, E.; Okuyama, Y.; Nakano, H. Eur. J. Org. Chem., 2016, 24, 4124.
[4]
(a) Bhagavathula, D.S.; Boddeti, G.; Venu, R. Res. Rev. J. Chem., 2017, 6, 27.
(b) Kinage1, A.K.; Upare, P.P.; Shivarkar, A.B.; Gupte, S.P. Green Sustain. Chem., 2011, 1, 76.
(b) Kinage1, A.K.; Upare, P.P.; Shivarkar, A.B.; Gupte, S.P. Green Sustain. Chem., 2011, 1, 76.
[6]
(a) Metro, T.X.; D.Pardo, D.G Cossy, J. Chem.Eur. J, 2008, 15, 1064.
(b) Metro, T.X. Appenzeller. J.; Gomezpardo, D.; Cossy, J. J. Org. Chem., 2007, 72, 6556.
(b) Metro, T.X. Appenzeller. J.; Gomezpardo, D.; Cossy, J. J. Org. Chem., 2007, 72, 6556.
[8]
Kim, J.W.; Kim, Y.W.; Inagaki, Y.; Hwang, Y.A.; Mitsutake, S.; Ryu, Y.W.; Lee, W.K.; Ha, H.J.; Park, C.S.; Igarashi, Y. Bioorg. Med. Chem., 2005, 13, 3475.
[9]
Kim, K.; Kim, Y.L.; Sacket, S.J.; Kim, H.L.; Han, M.; Park, D.S.; Lee, B.K.; Lee, W.K.; Ha, H.J. Im, D.S. J. Pharm. Pharmacol., 2007, 59, 1035.
[10]
Reilly, M.C.O.; Lindsley, C.W. Org. Let., 2012, 14, 2910; (b) Lau, Y.Y.; Zhai, H.; Schafer, L.L. J. Org. Chem., 2016, 81, 8696; (c) Dugar, S.; Sharma, A.; Kuila, B.; Mahajan, D.; Dwivedi, S.; Tripathi, V. Synthesis,2015, 47, 712; (d) Bornholdt, J.; Felding, J.; Kristiansen, J.L. J. Org. Chem., 2010, 75, 7454; (e) Lindsley, C.W. Hopkins, C.R. J. Med. Chem., 2017, 60, 7233.
[12]
(a) Brown, G.R.; Forster, G.; Foubister, A.J.; Stribling, D. J. Pharm. Pharmacol., 1990, 42, 797.
(b) D’Arrigo, P.; Lattanzio, M.; Fantoni, G.P.; Servi, S. Tetrahedron Asymmetry, 1998, 9, 4021.
(b) D’Arrigo, P.; Lattanzio, M.; Fantoni, G.P.; Servi, S. Tetrahedron Asymmetry, 1998, 9, 4021.
[13]
Banks, M.L.; Blough, B.E.; Fennell, T.R.; Snyder, R.W.; Negus, S.S. Drug Alcohol Depend., 2013, 130, 158.
[15]
Rapoport, B.L.; Jordan, K.; Boice, J.A.; Taylor, A.; Brown, C.; Hardwick, J.S.; Carides, A.; Webb, T.; Schmoll, H.J. Support. Care Cancer, 2010, 18, 423.
[16]
(a) Versiani, M.; Cassano, G.; Perugi, G.; Benedetti, A.; Mastalli, L.; Nardi, A.; Savino, M. J. Clin. Psychiatry, 2002, 63, 31.